Company / Gross Margin
Neogen Gross Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
47.1%
FY2024
5-year range
46.1% / 50.2%
FY2020-FY2024
Trend
-6.2%
vs FY2023
Sector context
#63 of 91
Health Care
What the data says
At 47.1%, Neogen's gross margin ranks #63 of 91 in the Health Care sector. Gross Margin remained relatively stable over the past 9 years, with values between 45.9% and 50.2%.
Based on SEC 10-K filings.
47.1% in FY2024 with a 5-year CAGR of +0.2%.
Declined from 49.4% to 47.1% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +1.0pp
- 5-Year Change
- +0.2pp
- 10-Year Change
- -
Sector benchmark
#63 of 91 in Health CareTop 69% of 91This company 47.1% Sector average 53.8%
▼
-12.4% below sector average
Key checks
Key Insights
- In FY2024, gross margin decreased 6.2% year-over-year.
- Currently 6.7pp below the Health Care sector average.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 47.1% | -6.2% |
| FY2023 | 50.2% | +1.7% |
| FY2022 | 49.4% | +7.1% |
| FY2021 | 46.1% | +0.4% |
| FY2020 | 45.9% | -2.2% |
| FY2019 | 46.9% | +1.3% |
| FY2018 | 46.3% | -1.0% |
| FY2017 | 46.8% | -0.7% |
| FY2016 | 47.1% | -1.0% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026